D441 Medical Dosage Calculations and Pharmacology - Set 5 - Part 1

Correct Answer: Pharmacokinetic transport types

Option c is correct because albuterol is a short-acting beta2 agonist and the only rescue inhaler approved for acute asthma attacks, providing rapid bronchodilation during severe respiratory distress episodes. Option a is incorrect because salmeterol is a long-acting beta2 agonist used for daily asthma control maintenance, not for treating acute asthma attacks or providing immediate rescue bronchodilation during respiratory emergencies. Option b is incorrect because fluticasone is an inhaled corticosteroid used for long-term asthma inflammation control and should never be used as the first-line treatment during an acute asthma attack episode. Option d is incorrect because montelukast is a leukotriene receptor antagonist used for chronic asthma prevention and is administered orally, making it unsuitable for rapid relief during acute asthma emergencies.

Correct Answer: Use albuterol first, wait five minutes

Option a is correct because bronchodilators like albuterol should be administered before inhaled glucocorticoids like fluticasone, with a five-minute wait to open airways and allow better corticosteroid absorption and deeper penetration. Option b is incorrect because fluticasone is a glucocorticoid that should be used after the bronchodilator, not before, since airways need to be opened first for the corticosteroid to reach deeper lung tissue effectively. Option c is incorrect because using both inhalers simultaneously does not allow the bronchodilator to open airways before the corticosteroid is administered, reducing the overall effectiveness of the glucocorticoid medication delivery. Option d is incorrect because alternating puffs between two different inhalers is not a recognized administration technique and would prevent the proper sequential airway opening needed before corticosteroid delivery to lung tissue.

Correct Answer: Notify the healthcare provider immediately

Option d is correct because when albuterol fails to provide relief after three doses, the nurse must immediately notify the healthcare provider, as this indicates worsening respiratory status requiring escalated medical intervention beyond rescue therapy. Option a is incorrect because continuing to administer albuterol after three unsuccessful doses without provider notification is inappropriate, as repeated ineffective treatments delay necessary escalated interventions for deteriorating respiratory function and oxygenation. Option b is incorrect because salmeterol is a long-acting beta2 agonist intended for daily maintenance therapy only and should never be used to treat an acute asthma attack or replace rescue inhaler failure situations. Option c is incorrect because simply instructing the patient to rest does not address the critical respiratory deterioration indicated by an oxygen saturation below ninety percent and continued wheezing after failed rescue treatments.

Correct Answer: Oxygen saturation reads ninety-two percent

Option b is correct because an oxygen saturation of ninety percent or higher, combined with a decreased respiratory rate, confirms effective bronchodilation from albuterol, indicating improved gas exchange and adequate oxygenation throughout body tissues. Option a is incorrect because hand tremors are a common side effect of albuterol related to beta2 receptor stimulation in skeletal muscle and do not serve as an indicator of therapeutic effectiveness or improved respiratory function. Option c is incorrect because an increased heart rate of one hundred ten is a side effect called tachycardia from beta2 agonist stimulation and represents an adverse reaction rather than evidence of successful asthma treatment outcomes. Option d is incorrect because sleepiness is not an expected therapeutic response to albuterol, which typically causes insomnia and restlessness as side effects, and drowsiness may indicate worsening hypoxia requiring further immediate assessment.

Correct Answer: Take it every twelve hours consistently

Option a is correct because salmeterol is a long-acting beta2 agonist that must be taken every twelve hours on a consistent schedule, even without symptoms, to maintain ongoing airway control and prevent asthma exacerbations. Option b is incorrect because salmeterol is a long-acting maintenance medication that cannot be used as a rescue inhaler during acute breathing episodes, as it lacks the rapid onset needed for immediate bronchodilation during emergencies. Option c is incorrect because salmeterol requires twice-daily administration every twelve hours to maintain consistent therapeutic blood levels and airway control, not weekly dosing which would provide no sustained clinical benefit. Option d is incorrect because while exercise-induced bronchospasm prevention may involve other medications, salmeterol is prescribed as a regular twice-daily controller medication and is not intended for situational pre-exercise use only.

Correct Answer: Discontinue medication and seek emergency care

Option d is correct because facial swelling and dyspnea are hallmark signs of angioedema, a life-threatening allergic reaction to ACE inhibitors requiring immediate medication discontinuation and emergency medical evaluation to prevent airway compromise. Option a is incorrect because angioedema from ACE inhibitors is a serious, potentially fatal reaction that cannot be adequately managed with antihistamines alone and requires immediate emergency intervention including medication discontinuation and airway management. Option b is incorrect because elevating the head of bed may provide minor comfort but does not address the underlying angioedema crisis, which requires immediate medication discontinuation and emergency medical care to prevent complete airway obstruction. Option c is incorrect because scheduling a follow-up appointment for the next day dangerously delays treatment for angioedema, which can rapidly progress to complete airway obstruction and death without immediate emergenc

Correct Answer: Hyperkalemia from potassium retention

Option c is correct because ACE inhibitors like enalapril cause potassium retention by reducing aldosterone secretion, and combining them with potassium supplements and potassium-rich foods significantly increases the dangerous risk of hyperkalemia. Option a is incorrect because while ACE inhibitors promote sodium and water excretion, the primary electrolyte concern when a patient simultaneously takes potassium supplements with an ACE inhibitor is elevated potassium, not sodium depletion. Option b is incorrect because ACE inhibitors do not significantly affect calcium metabolism or excretion, and hypocalcemia is not a recognized electrolyte disturbance associated with enalapril or other medications in the ACE inhibitor drug class. Option d is incorrect because magnesium wasting is not a characteristic side effect of ACE inhibitors like enalapril, and hypomagnesemia is more commonly associated with loop diuretics or proton pump inhibitor therapy rather than ACE inhibitor medications.

Correct Answer: Switch to an ARB like losartan

Option a is correct because ARBs are recommended alternatives when ACE inhibitor side effects like persistent cough become intolerable, and losartan is specifically noted as a preferred replacement in the African American population for blood pressure management. Option b is incorrect because adding a cough suppressant does not address the underlying cause of ACE inhibitor-induced cough related to bradykinin accumulation, and the appropriate intervention is switching to a different antihypertensive medication class entirely. Option c is incorrect because increasing the captopril dosage would likely worsen the persistent dry cough rather than resolve it, since the cough is a dose-independent class effect of all ACE inhibitors related to bradykinin buildup. Option d is incorrect because discontinuing all antihypertensive therapy would leave the patient's hypertension uncontrolled, creating serious cardiovascular risks, when simply switching to an alternative drug class would manage

Correct Answer: NSAIDs can reduce ramipril antihypertensive effectiveness

Option b is correct because NSAIDs like ibuprofen reduce the hypotensive effects of ACE inhibitors like ramipril by promoting sodium and water retention, which counteracts the vasodilation and blood pressure lowering intended by the prescribed medication. Option a is incorrect because NSAIDs do not enhance the blood pressure lowering effects of ACE inhibitors; they work in the opposite direction by reducing antihypertensive effectiveness through sodium and water retention mechanisms in the kidneys. Option c is incorrect because while both medications carry individual bleeding risks, the primary interaction between NSAIDs and ACE inhibitors is the reduction of antihypertensive effectiveness, not a significant increase in combined bleeding risk. Option d is incorrect because ibuprofen does not prevent or reduce ACE inhibitor-induced cough, and the primary concern with concurrent NSAID and ACE inhibitor use is the decreased blood pressure lowering effect of the antihypertensive.

Correct Answer: Fetal toxicity leading to neonatal death

Option d is correct because both ACE inhibitors and ARBs like valsartan are contraindicated during the second and third trimesters of pregnancy due to the serious risk of fetal toxicity that can result in neonatal death. Option a is incorrect because while abrupt antihypertensive discontinuation can cause rebound effects, the primary and most critical concern with ARB use during pregnancy is direct fetal toxicity, not maternal rebound hypertension syndrome development. Option b is incorrect because valsartan does not cause gestational diabetes through drug interaction, and the primary pregnancy-related concern with ARBs is their well-documented teratogenic potential causing fetal toxicity and possible neonatal death. Option c is incorrect because placental abruption from vasodilation is not the recognized primary risk of ARB use during pregnancy; the critical danger is fetal toxicity from the medication crossing the placenta and affecting fetal development.

Correct Answer: Life-threatening rebound arrhythmias

Option b is correct because abrupt withdrawal of beta blockers like metoprolol can precipitate life-threatening arrhythmias, rebound hypertension, and myocardial ischemia, which is why these medications must always be tapered gradually under provider guidance. Option a is incorrect because rebound hyperkalemia is not a recognized consequence of abrupt beta blocker withdrawal; the primary dangers are cardiac-related events including arrhythmias, severe hypertension, and myocardial ischemia from sudden sympathetic nervous system rebound. Option c is incorrect because acute kidney failure is not a typical result of abruptly stopping beta blockers like metoprolol; the serious rebound effects are primarily cardiovascular, including dangerous arrhythmias and uncontrolled blood pressure elevation. Option d is incorrect because serotonin syndrome is associated with serotonergic medications like SSRIs and MAOIs, not with beta blocker withdrawal, and is completely unrelated to the mechanism of a

Correct Answer: Propranolol can trigger bronchospasm

Option c is correct because propranolol is a nonselective beta blocker that blocks both beta1 and beta2 receptors, and blocking beta2 receptors in the lungs can cause bronchospasm, making it contraindicated in patients with asthma history. Option a is incorrect because propranolol does not cause severe hyperglycemia; rather, beta blockers may mask signs of hypoglycemia in diabetic patients, and hyperglycemia is not the primary reason propranolol is contraindicated for asthmatic patients. Option b is incorrect because propranolol is not associated with worsening gastric acid reflux, and the critical concern for an asthmatic patient taking a nonselective beta blocker is the dangerous risk of bronchospasm from beta2 receptor blockade. Option d is incorrect because propranolol does not increase intraocular pressure; timolol, another beta blocker, is actually used to treat glaucoma by reducing intraocular pressure, and the asthma concern relates specifically to lung beta2 receptor blockade.

Correct Answer: Masking typical hypoglycemia warning signs

Option a is correct because beta blockers like atenolol can mask typical cardiovascular warning signs of hypoglycemia such as tachycardia and palpitations, making it difficult for diabetic patients to recognize dangerously low blood sugar. Option b is incorrect because while beta blockers may slightly affect glucose metabolism, their primary concern in diabetic patients is not directly elevating blood glucose but rather masking the sympathetic nervous system warning signs of hypoglycemic episodes. Option c is incorrect because beta blockers do not prevent insulin from working properly at the cellular receptor level; the specific danger is that they block the adrenergic symptoms that normally alert patients to falling blood glucose concentrations. Option d is incorrect because beta blockers do not cause diabetic ketoacidosis episodes, which result from severe insulin deficiency and are unrelated to the mechanism by which beta blockers mask hypoglycemia symptoms in diabetic patients taki

Correct Answer: Hold the medication and notify provider

Option d is correct because beta blockers should be held when systolic blood pressure is below ninety or heart rate is below sixty beats per minute, and the provider must be notified before administering the medication to this patient. Option a is incorrect because administering metoprolol when blood pressure is below ninety systolic and heart rate is below sixty would further decrease both values to potentially dangerous levels, violating standard hold parameters for beta blockers. Option b is incorrect because reducing the dose without provider authorization is outside nursing scope of practice, and the appropriate action when vital signs fall below hold parameters is to withhold the medication entirely and contact the provider. Option c is incorrect because simply waiting thirty minutes and rechecking vitals does not address the current below-threshold readings, and the standard protocol requires holding the medication and notifying the healthcare provider for new orders.

Correct Answer: I will change positions slowly always

Option b is correct because nonselective beta blockers like carvedilol cause orthostatic hypotension, and patients must be taught to change positions slowly to prevent dizziness, falls, and syncope from sudden blood pressure drops. Option a is incorrect because patients should never stop taking beta blockers abruptly due to dizziness, as sudden discontinuation can cause life-threatening rebound arrhythmias and hypertension; they should report symptoms to their provider instead of stopping. Option c is incorrect because beta blockers must be taken consistently every day regardless of how the patient feels, since skipping doses disrupts therapeutic blood levels and can trigger dangerous cardiovascular rebound effects including life-threatening arrhythmias. Option d is incorrect because doubling up on missed beta blocker doses is dangerous and can cause severe bradycardia and hypotension; patients should take the missed dose as soon as remembered unless close to the next scheduled time.

Correct Answer: Protamine sulfate per protocol

Option c is correct because protamine sulfate is the specific antidote for heparin toxicity and should be administered when the patient shows bleeding signs with an elevated aPTT significantly above the therapeutic range of sixty-five to one hundred five seconds. Option a is incorrect because vitamin K is the antidote for warfarin toxicity, not heparin toxicity, and administering vitamin K would not reverse the anticoagulant effects of heparin or stop the bleeding caused by excessive heparin anticoagulation. Option b is incorrect because digoxin immune fab is the specific antidote for digoxin toxicity, not heparin toxicity, and would have no effect on reversing the anticoagulant properties causing the patient's current bleeding episode from heparin. Option d is incorrect because flumazenil is the antidote for benzodiazepine overdose and has no role in reversing heparin's anticoagulant effects; it works on GABA receptors completely unrelated to the coagulation cascade mechanis

Correct Answer: Decreased vitamin K dietary intake

Option a is correct because warfarin works by antagonizing vitamin K, and a significant decrease in dietary vitamin K intake removes the natural counterbalance to warfarin's effects, leading to excessive anticoagulation and dangerously elevated INR values. Option b is incorrect because increased physical activity alone does not significantly alter warfarin metabolism or INR levels, and the clinical connection between reduced green vegetable intake and decreased vitamin K consumption directly explains the elevated laboratory result. Option c is incorrect because coffee consumption does not have a clinically significant interaction with warfarin that would explain a dramatically elevated INR, unlike the well-established relationship between reduced vitamin K intake and increased anticoagulant effect. Option d is incorrect because reduced sleep duration does not significantly affect warfarin's anticoagulant activity or INR levels, and the patient's decreased consumption of

Correct Answer: Withhold the dose and notify provider

Option d is correct because digoxin must be held when the apical pulse is below sixty beats per minute, and the combination of bradycardia with nausea and visual changes strongly suggests digoxin toxicity requiring immediate provider notification. Option a is incorrect because administering digoxin when heart rate is below sixty and the patient exhibits toxicity signs like nausea and visual disturbances would worsen the toxic effects and potentially cause fatal cardiac arrhythmias and further deterioration. Option b is incorrect because rechecking the pulse in fifteen minutes inappropriately delays intervention when clear signs of digoxin toxicity are already present, including bradycardia below sixty, gastrointestinal upset, and visual disturbances indicating dangerous drug accumulation. Option c is incorrect because giving the medication despite a heart rate below the hold parameter of sixty beats per minute and active toxicity symptoms directly violates standard nursing protocols an

Correct Answer: Increases sensitivity to digoxin toxicity

Option b is correct because hypokalemia makes the heart muscle more sensitive to digitalis, significantly increasing the possibility of developing digoxin toxicity even at normal therapeutic drug levels, creating a dangerous and potentially fatal situation. Option a is incorrect because hypokalemia does not decrease digoxin absorption from the gastrointestinal tract; low potassium levels alter cardiac cell membrane sensitivity, making the myocardium more susceptible to the toxic effects of digoxin therapy. Option c is incorrect because hypokalemia does not neutralize digoxin's therapeutic effects; paradoxically, it enhances the drug's cardiac effects to dangerous levels by increasing myocardial sensitivity, moving the drug effect from therapeutic to toxic range. Option d is incorrect because hypokalemia does not accelerate digoxin elimination through the kidneys; the concern is that low serum potassium increases cardiac sensitivity to digoxin, raising toxicity risk without ch

Correct Answer: Warfarin takes five to seven days therapeutically

Option c is correct because warfarin requires five to seven days to reach a therapeutic INR level of two to three, so heparin provides immediate anticoagulation coverage during the overlap period until warfarin achieves its full therapeutic effect. Option a is incorrect because neither heparin nor warfarin dissolves existing blood clots; both medications prevent new clot formation and extension of existing clots, and the overlap exists specifically because of warfarin's delayed onset of therapeutic action. Option b is incorrect because warfarin does not selectively work only on arterial clots; it prevents clotting throughout the entire vascular system by antagonizing vitamin K, and the overlap with heparin exists solely due to warfarin's delayed therapeutic onset. Option d is incorrect because heparin does not prevent warfarin's side effects; the two medications have different adverse effect profiles, and the clinical rationale for overlapping therapy is maintaining cont